Friday, July 31, 2026

KFDA Blocks Importation of Gummy Candies Containing Hemp Ingredients

In response to the surging misuse of...

The Gov’t That Quit: South Korea Says Peace Is Dead Unless The U.S. Saves Them

Unification Minister Chung Dong-young predicts increased North Korean hostility toward South Korea, emphasizing the need for proactive diplomacy.

Norway’s World Cup Journey at Risk: Can They Overcome the Cold Virus Before Facing England?

Norway's World Cup run faces challenges due to a cold virus outbreak among players, impacting their preparation for the quarterfinals.

Tag: loss

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Samsung Galaxy S26: How Chip Shortages Led to Historic Losses in Q2 2026

Samsung's Device eXperience division faces its first operating loss due to chipflation despite rising sales, impacted by soaring memory costs.

Eli Lilly’s Retatrutide: The Revolutionary Triple Hormone Treatment for Obesity – What You Need to Know

Eli Lilly's retatrutide shows promising results in Phase 3 trials, aiming for FDA approval for obesity and related conditions in 2027.

Kangstem Biotech Signs Organoid Technology Evaluation Agreement With Global Top Five Pharmaceutical Company

Kangstem Biotech has signed an agreement with a top pharmaceutical company to evaluate drug candidates using its hair follicle organoid platform.

Metabolic Surgery for Obese Seniors: A Safe Solution for Diabetes and Hypertension?

A study shows metabolic obesity surgery is safe for patients over 55, improving diabetes and other metabolic diseases effectively.

Discover Rhamsydil: LG’s AI-Driven Hair Loss Solution Set for 2026 Launch

LG AI Research reveals Rhamsydil, an AI-developed hair loss compound, showcasing Exaone tech at ICML 2026 in Seoul.

Wegovy, Mounjaro Boom Creates New Winners as Ursa, InBody Ride GLP-1 Ripple Effects

GLP-1 obesity drugs are boosting gallstone prevention therapies and body composition monitoring, creating new market opportunities.

Samsung Launches GLP-1 Muscle Loss Study With Galaxy Watch8 and Harvard-Linked Hospital

Samsung is researching muscle loss management for GLP-1 drug users, led by the Galaxy Watch 8.

Metavia Highlights Strong Early Weight-Loss Data for DA-1726 at EASL 2026

MetaVia's obesity treatment candidate 'DA-1726' shows safety and weight loss effects in Phase 1 trials after 54 days.

Significant Weight Loss Substantially Increases Mortality Risk in Dementia Patients

A study finds dementia patients with significant weight loss face higher mortality risks, while stable weight or moderate gain lowers risks.

Unlocking Weight Loss: How GB102 Probiotics Enhance GLP-1 Obesity Drugs

GI Longevity's GB102 probiotic enhances weight loss with GLP-1 medications, reducing rebound gain and improving blood sugar control.

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

JW Pharmaceutical Secures Phase 1 Approval for Novel Hair Loss Treatment JW0061—What to Expect?

JW Pharmaceutical is investing in innovative hair loss treatments and expanding its drug portfolio, including successful cholesterol medications.

Will South Korea’s Health Insurance Cover Youth Hair Loss Treatments?

South Korea's Ministry of Health reviews youth hair loss treatment for insurance coverage, emphasizing public debate and cost-effectiveness.

Eli Lilly’s New Weight Loss Pill Foundayo: A Game Changer in the GLP-1 Market?

The FDA has approved Eli Lilly's oral obesity drug Foundayo, enhancing competition in the weight loss market with flexible dosing.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.